These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7872880)

  • 1. Cerebral microembolism in patients with Sneddon's syndrome.
    Sitzer M; Söhngen D; Siebler M; Specker C; Rademacher J; Janda I; Aulich A; Steinmetz H
    Arch Neurol; 1995 Mar; 52(3):271-5. PubMed ID: 7872880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of antiphospholipid antibodies in a patient with Sneddon's syndrome and her family.
    Lousa M; Sastre JL; Cancelas JA; Gobernado JM; Pardo A
    Stroke; 1994 May; 25(5):1071-4. PubMed ID: 8165682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial Sneddon's syndrome: clinical, hematologic, and radiographic findings in two brothers.
    Pettee AD; Wasserman BA; Adams NL; McMullen W; Smith HR; Woods SL; Ratnoff OD
    Neurology; 1994 Mar; 44(3 Pt 1):399-405. PubMed ID: 8145905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cerebrovascular disorders associated with livedo (Sneddon's syndrome): its relation to lupus anticoagulant].
    Kalashnikova LA; Prudnikova LZ; Nasonov EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):104-7. PubMed ID: 2175072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sneddon's syndrome, anti-cardiolipin antibody and glomerular thrombosis.
    Stevens JM; Hunt JE; Seymour AE; Krilis SA; Pugsley DJ
    Clin Nephrol; 1994 Jan; 41(1):18-22. PubMed ID: 8137565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of Sneddon's syndrome.
    Schellong SM; Weissenborn K; Niedermeyer J; Wollenhaupt J; Sosada M; Ehrenheim C; Lubach D
    Vasa; 1997 Aug; 26(3):215-21. PubMed ID: 9286155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sneddon's syndrome: case report and review of its relationship with antiphospholipid syndrome.
    Dutra LA; Braga-Neto P; Pedroso JL; Barsottini OG
    Einstein (Sao Paulo); 2012; 10(2):230-2. PubMed ID: 23052460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].
    Vaillant L; Larmande P; Arbeille B; Desveaux B; Gruel Y; Lorette G
    Ann Dermatol Venereol; 1990; 117(12):925-30. PubMed ID: 2082786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral microembolism, a disease marker for ischemic cerebrovascular events in the antiphospholipid syndrome of systemic lupus erythematosus?
    Rademacher J; Söhngen D; Specker C; Janda I; Sitzer M
    Acta Neurol Scand; 1999 Jun; 99(6):356-61. PubMed ID: 10577269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticardiolipin antibodies in Sneddon's syndrome.
    Kalashnikova LA; Nasonov EL; Kushekbaeva AE; Gracheva LA
    Neurology; 1990 Mar; 40(3 Pt 1):464-7. PubMed ID: 2314589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Livedo reticularis and cerebrovascular accidents (Sneddon's syndrome) as a clinical expression of antiphospholipid syndrome.
    Gantcheva M; Tsankov N
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):157-60. PubMed ID: 10343946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sneddon's syndrome--clinical course and out-come.
    O'Riordan JI; Javed M; Murphy R; Hutchinson M
    Ir Med J; 1995; 88(2):66-7. PubMed ID: 7775150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sneddon's syndrome: its clinical characteristics and etiopathogenic factors].
    Sempere AP; Martínez B; Bermejo F; Tahoces ML; Cabello A
    Rev Clin Esp; 1992 Jun; 191(1):3-7. PubMed ID: 1631358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-beta 2 glycoprotein 1 antibodies in idiopathic livedo reticularis].
    Aubry F; Crickx B; Nicaise P; Labarre C; Viard JP; Belaïch S
    Ann Dermatol Venereol; 1995; 122(10):667-70. PubMed ID: 8687049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sneddon's syndrome is a thrombotic vasculopathy: neuropathologic and neuroradiologic evidence.
    Geschwind DH; FitzPatrick M; Mischel PS; Cummings JL
    Neurology; 1995 Mar; 45(3 Pt 1):557-60. PubMed ID: 7898716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anti-endothelial cell antibodies in patients with Sneddon's syndrome.
    Francès C; Le Tonquèze M; Salohzin KV; Kalashnikova LA; Piette JC; Godeau P; Nasonov EL; Youinou P
    J Am Acad Dermatol; 1995 Jul; 33(1):64-8. PubMed ID: 7601948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sneddon's syndrome and phospholipid antibodies.
    Mesa HA; Lang B; Schumacher M; Vaith P; Peter HH
    Clin Rheumatol; 1993 Jun; 12(2):253-6. PubMed ID: 8358989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, neurovascular and neuropathological features in Sneddon's syndrome.
    Marinho JL; Piovesan EJ; Leite Neto MP; Kotze LR; Noronha Ld; Twardowschy CA; Lange MC; Scola RH; Zétola VH; Nóvak EM; Werneck LC
    Arq Neuropsiquiatr; 2007 Jun; 65(2B):390-5. PubMed ID: 17665002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sneddon's syndrome and the primary antiphospholipid syndrome].
    Kalashnikova LA; Nasonov EL; Stoianovich LZ; Kovalev VIu; Kosheleva NM; Reshetniak TM
    Ter Arkh; 1993; 65(3):64-70. PubMed ID: 8059389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sneddon's syndrome, anticardiolipin antibodies and anticardiolipin cofactor. A case report.
    Sinisi L; Palma V; Di Girolamo C; Scarpa R; Faccenda F; Rubba P; Cirillo S; Mansi D
    Acta Neurol (Napoli); 1992 Apr; 14(2):134-9. PubMed ID: 1414558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.